{"id":66322,"date":"2026-05-26T14:19:10","date_gmt":"2026-05-26T06:19:10","guid":{"rendered":"https:\/\/flcube.com\/?p=66322"},"modified":"2026-05-26T14:19:12","modified_gmt":"2026-05-26T06:19:12","slug":"insilico-medicine-and-eterna-therapeutics-expand-ai-driven-partnership-into-skin-anti-aging-and-scientific-skincare","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=66322","title":{"rendered":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Insilico Medicine<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/3696:HKG\">HKG: 3696<\/a>), a <strong>generative artificial intelligence (AI)-driven biotechnology company<\/strong>, announced an <strong>expanded strategic partnership<\/strong> with fellow Chinese firm <strong>Eterna Therapeutics<\/strong>, a leader in <strong>protein liquid-liquid phase separation (LLPS) technology<\/strong> and <strong>innovative dermatological drug development<\/strong>, to accelerate the discovery and development of <strong>AI-empowered skin management solutions<\/strong> and <strong>innovative drugs for skin anti-aging<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-partnership-evolution-amp-strategic-scope\" class=\"wp-block-heading\">Partnership Evolution &amp; Strategic Scope<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Insilico Medicine (AI platform) \/ Eterna Therapeutics (LLPS technology)<\/td><\/tr><tr><td><strong>Original Focus<\/strong><\/td><td>Small-molecule protein degradation drug candidates for oncology targets<\/td><\/tr><tr><td><strong>Expanded Indications<\/strong><\/td><td>Scientific skincare and skin anti-aging therapeutics<\/td><\/tr><tr><td><strong>Technology Integration<\/strong><\/td><td>Insilico&#8217;s generative AI biology platform + Eterna&#8217;s proprietary LLPS platform<\/td><\/tr><tr><td><strong>Development Goal<\/strong><\/td><td>Translation of original small-molecule drugs from basic research to clinical application and commercial implementation<\/td><\/tr><tr><td><strong>Geographic Focus<\/strong><\/td><td>Global markets with initial focus on Asia-Pacific premium skincare segment<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The expanded collaboration leverages the complementary strengths of both companies, combining Insilico&#8217;s cutting-edge generative AI capabilities with Eterna&#8217;s deep expertise in protein phase separation biology applied to skin health.<\/p>\n\n\n\n<h2 id=\"h-technology-platforms-amp-innovation-rationale\" class=\"wp-block-heading\">Technology Platforms &amp; Innovation Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Insilico Medicine Platform:<\/strong><\/li>\n\n\n\n<li><strong>Generative AI-driven biology platform<\/strong> for target discovery and molecule generation<\/li>\n\n\n\n<li>Proven track record in accelerating drug discovery timelines by 50-70%<\/li>\n\n\n\n<li>Proprietary algorithms for predicting molecular properties and biological activity<\/li>\n\n\n\n<li><strong>Eterna Therapeutics Platform:<\/strong><\/li>\n\n\n\n<li><strong>Proprietary protein liquid-liquid phase separation (LLPS) technology<\/strong><\/li>\n\n\n\n<li>Deep expertise in skin biology and dermatological drug development<\/li>\n\n\n\n<li>Specialized knowledge in cellular organization and protein dynamics relevant to skin aging<\/li>\n\n\n\n<li><strong>Synergistic Innovation:<\/strong> The combination enables rational design of small molecules that can modulate LLPS processes critical to skin cell function, collagen production, and aging pathways<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-development-strategy-amp-market-opportunity\" class=\"wp-block-heading\">Development Strategy &amp; Market Opportunity<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Program Element<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Therapeutic Area<\/strong><\/td><td>Scientific skincare and skin anti-aging<\/td><\/tr><tr><td><strong>Product Class<\/strong><\/td><td>Original small-molecule drugs (pharmaceutical-grade skincare actives)<\/td><\/tr><tr><td><strong>Development Pathway<\/strong><\/td><td>Basic research \u2192 preclinical validation \u2192 clinical trials \u2192 commercial implementation<\/td><\/tr><tr><td><strong>Target Market<\/strong><\/td><td>Premium scientific skincare ($25B+ global market, 8% CAGR)<\/td><\/tr><tr><td><strong>Competitive Advantage<\/strong><\/td><td>First-mover advantage in AI-designed, LLPS-targeted skincare therapeutics<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership addresses the rapidly growing &#8220;cosmeceutical&#8221; market, where consumers increasingly demand scientifically validated, pharmaceutical-grade active ingredients with proven mechanisms of action for anti-aging benefits.<\/p>\n\n\n\n<h2 id=\"h-market-impact-amp-commercial-outlook\" class=\"wp-block-heading\">Market Impact &amp; Commercial Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scientific Skincare Trend:<\/strong> Global shift toward evidence-based skincare products with pharmaceutical backing creates significant opportunity for AI-discovered molecules<\/li>\n\n\n\n<li><strong>Regulatory Pathway:<\/strong> Dual-track development possible \u2013 cosmetic ingredients (faster market entry) and pharmaceutical therapeutics (premium pricing, exclusivity)<\/li>\n\n\n\n<li><strong>IP Strategy:<\/strong> Strong patent protection expected for novel small molecules discovered through the AI-LLPS combination approach<\/li>\n\n\n\n<li><strong>Revenue Model:<\/strong> Multiple streams including direct product sales, licensing to premium skincare brands, and potential pharmaceutical partnerships<\/li>\n\n\n\n<li><strong>Timeline Acceleration:<\/strong> AI-driven discovery expected to reduce typical 5-7 year skincare ingredient development timeline by 40-60%<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding partnership agreements, technology integration, product development, and commercial expectations. Actual results may differ due to risks including technical feasibility, regulatory decisions, market adoption, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic&#8230;<\/p>\n","protected":false},"author":1,"featured_media":66323,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4756,4514,164,100],"class_list":["post-66322","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-eterna-therapeutics","tag-hkg-3696","tag-insilico-medicine","tag-medical-aesthetics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic partnership with fellow Chinese firm Eterna Therapeutics, a leader in protein liquid-liquid phase separation (LLPS) technology and innovative dermatological drug development, to accelerate the discovery and development of AI-empowered skin management solutions and innovative drugs for skin anti-aging.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=66322\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic partnership with fellow Chinese firm Eterna Therapeutics, a leader in protein liquid-liquid phase separation (LLPS) technology and innovative dermatological drug development, to accelerate the discovery and development of AI-empowered skin management solutions and innovative drugs for skin anti-aging.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=66322\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T06:19:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-26T06:19:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare\",\"datePublished\":\"2026-05-26T06:19:10+00:00\",\"dateModified\":\"2026-05-26T06:19:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322\"},\"wordCount\":468,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2602.webp\",\"keywords\":[\"Eterna Therapeutics\",\"HKG: 3696\",\"Insilico Medicine\",\"Medical aesthetics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66322#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=66322\",\"name\":\"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2602.webp\",\"datePublished\":\"2026-05-26T06:19:10+00:00\",\"dateModified\":\"2026-05-26T06:19:12+00:00\",\"description\":\"Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic partnership with fellow Chinese firm Eterna Therapeutics, a leader in protein liquid-liquid phase separation (LLPS) technology and innovative dermatological drug development, to accelerate the discovery and development of AI-empowered skin management solutions and innovative drugs for skin anti-aging.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66322\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2602.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2602.webp\",\"width\":1080,\"height\":608,\"caption\":\"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66322#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare - Insight, China&#039;s Pharmaceutical Industry","description":"Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic partnership with fellow Chinese firm Eterna Therapeutics, a leader in protein liquid-liquid phase separation (LLPS) technology and innovative dermatological drug development, to accelerate the discovery and development of AI-empowered skin management solutions and innovative drugs for skin anti-aging.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=66322","og_locale":"en_US","og_type":"article","og_title":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare","og_description":"Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic partnership with fellow Chinese firm Eterna Therapeutics, a leader in protein liquid-liquid phase separation (LLPS) technology and innovative dermatological drug development, to accelerate the discovery and development of AI-empowered skin management solutions and innovative drugs for skin anti-aging.","og_url":"https:\/\/flcube.com\/?p=66322","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-26T06:19:10+00:00","article_modified_time":"2026-05-26T06:19:12+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=66322#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=66322"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare","datePublished":"2026-05-26T06:19:10+00:00","dateModified":"2026-05-26T06:19:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=66322"},"wordCount":468,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=66322#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp","keywords":["Eterna Therapeutics","HKG: 3696","Insilico Medicine","Medical aesthetics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=66322#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=66322","url":"https:\/\/flcube.com\/?p=66322","name":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=66322#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=66322#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp","datePublished":"2026-05-26T06:19:10+00:00","dateModified":"2026-05-26T06:19:12+00:00","description":"Insilico Medicine (HKG: 3696), a generative artificial intelligence (AI)-driven biotechnology company, announced an expanded strategic partnership with fellow Chinese firm Eterna Therapeutics, a leader in protein liquid-liquid phase separation (LLPS) technology and innovative dermatological drug development, to accelerate the discovery and development of AI-empowered skin management solutions and innovative drugs for skin anti-aging.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=66322#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=66322"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=66322#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp","width":1080,"height":608,"caption":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=66322#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Insilico Medicine and Eterna Therapeutics Expand AI-Driven Partnership into Skin Anti-Aging and Scientific Skincare"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2602.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=66322"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66322\/revisions"}],"predecessor-version":[{"id":66324,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66322\/revisions\/66324"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/66323"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=66322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=66322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=66322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}